U.S. Sen. Baldwin: Joins colleagues to raise concerns about potential patent infringement by pharmaceutical company Gilead Sciences and high price of its HIV-prevention drug, Truvada
Contact: press@baldwin.senate.gov 202-224-6225 WASHINGTON, D.C. – U.S. Senator Tammy Baldwin joined her Senate colleagues to raise concerns about reports that pharmaceutical company Gilead Sciences is profiting from an HIV-prevention drug that infringes upon patents owned by the United States Government and selling it